| 1 | Lymphoma, Non-Hodgkin | 47.8% |
| 2 | Composite Lymphoma | 46.7% |
| 3 | Sezary Syndrome | 37% |
| 4 | Lymphoma, Follicular | 35.5% |
| 5 | T-Cell Lymphoma | 35.5% |
| 6 | Mantle cell lymphoma | 35.5% |
| 7 | Lymphoma, T-Cell, Cutaneous | 29.4% |
| 8 | Lymphoma, AIDS-Related | 29.4% |
| 9 | Enteropathy-Associated T-Cell Lymphoma | 29.4% |
| 10 | Primary Effusion Lymphoma | 29.4% |
| 11 | Lymphomatoid Granulomatosis | 28.4% |
| 12 | Tumor Lysis Syndrome | 27.6% |
| 13 | Mycosis Fungoides | 26.4% |
| 14 | Lymphomatoid Papulosis | 26.4% |
| 15 | Plasmablastic lymphoma | 26.4% |
| 16 | Autoimmune Lymphoproliferative Syndrome | 22.6% |
| 17 | Burkitt Lymphoma | 22.2% |
| 18 | Plasmacytoma | 21.7% |
| 19 | Lymphangioleiomyomatosis | 21.3% |
| 20 | Infectious Mononucleosis | 21.1% |
| 21 | Leukemia, T-Cell | 20% |
| 22 | Leukemia, B-Cell | 20% |
| 23 | Primary amyloidosis | 19.7% |
| 24 | Leukemia, Plasma Cell | 19% |
| 25 | Histiocytic Disorders, Malignant | 18% |
| 26 | Heavy Chain Disease | 17.5% |
| 27 | Sarcoidosis | 17.2% |
| 28 | Waldenstrom Macroglobulinemia | 16.8% |
| 29 | Multiple Myeloma | 16.8% |
| 30 | Neoplasms, Neuroepithelial | 16.3% |
| 31 | Gliomatosis cerebri | 16.3% |
| 32 | Agammaglobulinemia | 16.1% |
| 33 | Neuroectodermal Tumors | 15.8% |
| 34 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 15.3% |
| 35 | Leukemia, Large Granular Lymphocytic | 15.3% |
| 36 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 15.3% |
| 37 | leukemia | 15% |
| 38 | Neoplasms, Germ Cell and Embryonal | 15% |
| 39 | Neoplasms, Glandular and Epithelial | 15% |
| 40 | Germ Cell Cancer | 15% |
| 41 | Medulloblastoma | 14.9% |
| 42 | melanoma | 14.6% |
| 43 | Lymphocele | 14.2% |
| 44 | Lymphoma, Extranodal NK-T-Cell | 14.2% |
| 45 | Granuloma | 14% |
| 46 | Carcinosarcoma | 13.7% |
| 47 | Hemangiosarcoma | 13.7% |
| 48 | lymphangiosarcoma | 13.7% |
| 49 | Thymoma | 13.1% |
| 50 | Adenoma, Acidophil | 12.9% |
| 51 | Ganglioneuroma | 12.9% |
| 52 | Glioma | 12.9% |
| 53 | Malignant Glioma | 12.9% |
| 54 | Thymus Neoplasms | 12.7% |
| 55 | Adenitis | 12.5% |
| 56 | Histiocytosis | 12.5% |
| 57 | Lymphadenitis | 12.5% |
| 58 | Lymphangitis | 12.5% |
| 59 | Lymphedema | 12.5% |
| 60 | Splenic Diseases | 12.5% |
| 61 | Thymus Hyperplasia | 12.5% |
| 62 | Pseudolymphoma | 12.5% |
| 63 | Lymphadenopathy | 12.5% |
| 64 | Meningioma | 12.4% |
| 65 | Carcinoma 256, Walker | 12.3% |
| 66 | Carcinoid Tumor | 12.1% |
| 67 | Neurilemmoma | 12.1% |
| 68 | Hutchinson's Melanotic Freckle | 12.1% |
| 69 | Melanoma, Amelanotic | 12.1% |
| 70 | Paraproteinemias | 12% |
| 71 | Malignant histiocytosis | 11.8% |
| 72 | Histiocytic sarcoma | 11.8% |
| 73 | Basal cell carcinoma | 11.7% |
| 74 | Carcinoma, Papillary | 11.7% |
| 75 | Squamous cell carcinoma | 11.7% |
| 76 | Chondrosarcoma | 11.7% |
| 77 | Craniopharyngioma | 11.7% |
| 78 | Cystadenoma | 11.7% |
| 79 | leiomyosarcoma | 11.7% |
| 80 | liposarcoma | 11.7% |
| 81 | Mesothelioma | 11.7% |
| 82 | synovial sarcoma | 11.7% |
| 83 | Neuroectodermal Tumor, Melanotic | 11.7% |
| 84 | Angiomyolipoma | 11.7% |
| 85 | Clear Cell Sarcoma of Soft Tissue | 11.7% |
| 86 | Alveolar Soft Part Sarcoma | 11.7% |
| 87 | Neuroendocrine Tumors | 11.7% |
| 88 | Sarcoma, Myeloid | 11.7% |
| 89 | Carcinoma, Basal Cell | 11.7% |
| 90 | Melanoma, Experimental | 11.6% |
| 91 | Astrocytoma | 11.2% |
| 92 | Ependymoma | 11.2% |
| 93 | oligodendroglioma | 11.2% |
| 94 | Ganglioglioma | 11.2% |
| 95 | gliosarcoma | 11.2% |
| 96 | Anaplastic astrocytoma | 11.2% |
| 97 | Anaplastic Oligodendroglioma | 11.2% |
| 98 | Malignant Carcinoid Syndrome | 10.8% |
| 99 | Cystadenocarcinoma | 10.7% |
| 100 | Fibrosarcoma | 10.7% |
| 101 | Osteosarcoma | 10.7% |
| 102 | Mucoepidermoid Carcinoma | 10.7% |
| 103 | Glioblastoma | 10.4% |
| 104 | Neuroblastoma | 10.4% |
| 105 | Glioblastoma Multiforme | 10.4% |
| 106 | Monoclonal Gammopathy of Undetermined Significance | 10.3% |
| 107 | Adenofibroma | 10.2% |
| 108 | Fibroadenoma | 10.2% |
| 109 | Malignant Fibrous Histiocytoma | 10.2% |
| 110 | Lymphatic Abnormalities | 10.1% |
| 111 | Hypergammaglobulinemia | 10.1% |
| 112 | Splenic Neoplasms | 10% |
| 113 | Trophoblastic Neoplasms | 10% |
| 114 | Ganglioneuroblastoma | 10% |
| 115 | Leukemia, Experimental | 9.9% |
| 116 | Carcinoma, Ehrlich Tumor | 9.9% |
| 117 | Dermoid Cyst | 9.9% |
| 118 | Carcinoma, Lewis Lung | 9.9% |
| 119 | Lymphangiectasis, Intestinal | 9.9% |
| 120 | Adenoma | 9.8% |
| 121 | Ameloblastoma | 9.8% |
| 122 | Angiokeratoma | 9.8% |
| 123 | Carcinoma | 9.8% |
| 124 | Chordoma | 9.8% |
| 125 | Hemangioma | 9.8% |
| 126 | hemangiopericytoma | 9.8% |
| 127 | Lymphangioma | 9.8% |
| 128 | Mesenchymoma | 9.8% |
| 129 | Nevus | 9.8% |
| 130 | Teratoma | 9.8% |
| 131 | Hepatoblastoma | 9.8% |
| 132 | Mixed Tumor, Mullerian | 9.8% |
| 133 | Germinoma | 9.8% |
| 134 | Teratocarcinoma | 9.8% |
| 135 | Angiofibroma | 9.8% |
| 136 | Sarcoma | 9.8% |
| 137 | Epithelioma | 9.8% |
| 138 | Transfusion Reaction | 9.7% |
| 139 | Hypotensive Transfusion Reaction | 9.7% |
| 140 | Bowen's Disease | 9.7% |
| 141 | Paraganglioma | 9.7% |
| 142 | Rhabdomyosarcoma | 9.7% |
| 143 | Giant Cell Tumor of Bone | 9.7% |
| 144 | Choriocarcinoma | 9.5% |
| 145 | Carcinoma, Lobular | 9.5% |
| 146 | Dermatofibrosarcoma | 9.2% |
| 147 | Dermatofibrosarcoma Protuberans | 9.2% |
| 148 | Sarcoidosis, Pulmonary | 9.2% |
| 149 | Endometrial Stromal Sarcoma | 9% |
| 150 | Carcinoid Heart Disease | 8.9% |
| 151 | Retinoblastoma | 8.9% |
| 152 | Neurofibrosarcoma | 8.7% |
| 153 | Pheochromocytoma | 8.7% |
| 154 | Alveolar rhabdomyosarcoma | 8.7% |
| 155 | Hamartoma | 8.6% |
| 156 | Neoplasms, Hormone-Dependent | 8.6% |
| 157 | Neoplasms, Multiple Primary | 8.6% |
| 158 | Paraneoplastic Syndromes | 8.6% |
| 159 | Precancerous Conditions | 8.6% |
| 160 | Neoplasms, Second Primary | 8.6% |
| 161 | Leukemia, Radiation-Induced | 8.6% |
| 162 | Leukemia L1210 | 8.5% |
| 163 | Leukemia P388 | 8.5% |
| 164 | Acanthoma | 8.5% |
| 165 | Mucocutaneous Lymph Node Syndrome | 8.3% |
| 166 | Sarcoma, Experimental | 8.2% |
| 167 | Autoimmune Diseases | 7.8% |
| 168 | Hypersensitivity | 7.8% |
| 169 | Immunologic Deficiency Syndromes | 7.8% |
| 170 | Immune reconstitution syndrome | 7.8% |
| 171 | Immune Reconstitution Inflammatory Syndrome | 7.8% |
| 172 | Sarcoma 180 | 7.5% |
| 173 | Hematologic Neoplasms | 7.4% |
| 174 | Elephantiasis | 7.4% |
| 175 | Hypersplenism | 7.4% |
| 176 | Elephantiasis Nostras Verrucosa | 7.4% |
| 177 | Adenocarcinoma | 7.3% |
| 178 | Carcinoma in Situ | 7.3% |
| 179 | Carcinoma, Transitional Cell | 7.3% |
| 180 | Phyllodes Tumor | 7.3% |
| 181 | Dysgerminoma | 7.3% |
| 182 | Hemangioendothelioma | 7.3% |
| 183 | Lipoma | 7.3% |
| 184 | Myoma | 7.3% |
| 185 | Myxoma | 7.3% |
| 186 | Neuroma | 7.3% |
| 187 | Papilloma | 7.3% |
| 188 | Pseudomyxoma Peritonei | 7.3% |
| 189 | Seminoma | 7.3% |
| 190 | Papillomatosis | 7.3% |
| 191 | Angiolipoma | 7.3% |
| 192 | Myelolipoma | 7.3% |
| 193 | Neoplasms, Bone Tissue | 7.3% |
| 194 | Neoplasms, Fibrous Tissue | 7.3% |
| 195 | Smooth Muscle Tumor | 7.3% |
| 196 | Adenomatosis, Pulmonary | 7.3% |
| 197 | Adenomatous Polyps | 7.3% |
| 198 | Carcinoma, Large Cell | 7.3% |
| 199 | Carcinoma, Small Cell | 7.3% |
| 200 | Desmoplastic Small Round Cell Tumor | 7.3% |
| 201 | Chondroma | 7.3% |
| 202 | Enchondroma | 7.3% |
| 203 | Leukemia, Myelomonocytic, Chronic | 7.1% |
| 204 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 7.1% |
| 205 | Acoustic Neuroma | 7% |
| 206 | Cyst | 6.9% |
| 207 | Neoplastic Processes | 6.9% |
| 208 | Neoplastic Syndromes, Hereditary | 6.9% |
| 209 | Pregnancy Complications, Neoplastic | 6.9% |
| 210 | Neoplasms, Experimental | 6.8% |
| 211 | Multiple Endocrine Neoplasia | 6.8% |
| 212 | Mastocytosis | 6.6% |
| 213 | Carcinoma, Pancreatic Ductal | 6.6% |
| 214 | Basal Cell Nevus Syndrome | 6.4% |
| 215 | Optic Nerve Glioma | 6.4% |
| 216 | Mastocytosis, Systemic | 6.1% |
| 217 | Nephroblastoma | 6.1% |
| 218 | Cryoglobulinemia | 6.1% |
| 219 | Adenoid Cystic Carcinoma | 6.1% |
| 220 | fibroma | 6.1% |
| 221 | Fibromatosis | 6.1% |
| 222 | Osteoblastoma | 6.1% |
| 223 | Osteoma | 6.1% |
| 224 | Rhabdomyoma | 6.1% |
| 225 | Chondromatosis | 6.1% |
| 226 | Adenocarcinoma, Clear Cell | 6.1% |
| 227 | Cholangiocarcinoma | 6.1% |
| 228 | Cervical Intraepithelial Neoplasia | 6.1% |
| 229 | Hemangioblastoma | 6.1% |
| 230 | Splenic Infarction | 6% |
| 231 | Hemangioma, Cavernous | 6% |
| 232 | Vipoma | 5.9% |
| 233 | Histiocytosis, Langerhans-Cell | 5.9% |
| 234 | Leukemia, Myeloid, Chronic-Phase | 5.8% |
| 235 | Neoplasms, Radiation-Induced | 5.7% |
| 236 | Hydatidiform Mole | 5.6% |
| 237 | Paraneoplastic Encephalomyelitis | 5.6% |
| 238 | Hepatocellular Adenoma | 5.6% |
| 239 | Mammary Neoplasms, Experimental | 5.5% |
| 240 | Bone Marrow Neoplasms | 5.5% |
| 241 | Fibromatosis, Aggressive | 5.5% |
| 242 | Fibromatosis, Abdominal | 5.5% |
| 243 | Klatskin Tumor | 5.5% |
| 244 | Mesoblastic Nephroma | 5.2% |
| 245 | Thrombocytopenic purpura | 5.2% |
| 246 | Autoimmune thrombocytopenia | 5.2% |
| 247 | Immune thrombocytopenic purpura | 5.2% |
| 248 | POEMS Syndrome | 5.1% |
| 249 | Splenic Rupture | 5.1% |
| 250 | Tuberous Sclerosis | 5% |
| 251 | Glomerulonephritis, Membranoproliferative | 5% |
| 252 | Abdominal Neoplasms | 5% |
| 253 | Erythroplasia | 5% |
| 254 | Follicular cyst | 5% |
| 255 | Head and Neck Neoplasms | 5% |
| 256 | Mucocele | 5% |
| 257 | Pilonidal Cyst | 5% |
| 258 | Soft Tissue Neoplasms | 5% |
| 259 | Thoracic Neoplasms | 5% |
| 260 | Thyroglossal Cyst | 5% |
| 261 | Synovial Cyst | 5% |
| 262 | Aberrant Crypt Foci | 5% |
| 263 | Sturge-Weber Syndrome | 5% |
| 264 | Disseminated Intravascular Coagulation | 4.9% |
| 265 | Protein S Deficiency | 4.9% |
| 266 | Gastrointestinal Stromal Tumors | 4.9% |
| 267 | Mastocytoma | 4.9% |
| 268 | Prolactinoma | 4.9% |
| 269 | Growth Hormone-Secreting Pituitary Adenoma | 4.9% |
| 270 | Lymphohistiocytosis, Hemophagocytic | 4.9% |
| 271 | Schnitzler Syndrome | 4.9% |
| 272 | Erdheim-Chester Disease | 4.9% |
| 273 | neurofibroma | 4.9% |
| 274 | Lymphopenia | 4.6% |
| 275 | Multiple Endocrine Neoplasia Type 1 | 4.5% |
| 276 | insulinoma | 4.5% |
| 277 | Thrombocythemia, Essential | 4.4% |
| 278 | Transfusion-Related Acute Lung Injury | 4.4% |
| 279 | granulosa cell tumor | 4.3% |
| 280 | Carcinoma, Ovarian Epithelial | 4.3% |
| 281 | Adenomatous Polyposis Coli | 4.3% |
| 282 | Gastrinoma | 4.2% |
| 283 | Glucagonoma | 4.2% |
| 284 | Anemia | 4.2% |
| 285 | Blood Coagulation Disorders | 4.2% |
| 286 | Blood Platelet Disorders | 4.2% |
| 287 | Bone Marrow Diseases | 4.2% |
| 288 | Digestive System Neoplasms | 4.2% |
| 289 | Endocrine Gland Neoplasms | 4.2% |
| 290 | Eye Neoplasms | 4.2% |
| 291 | Hemorrhagic Disorders | 4.2% |
| 292 | Immune Complex Diseases | 4.2% |
| 293 | Leukocyte Disorders | 4.2% |
| 294 | Methemoglobinemia | 4.2% |
| 295 | Nervous System Neoplasms | 4.2% |
| 296 | Pancytopenia | 4.2% |
| 297 | Polycythemia | 4.2% |
| 298 | Polycythemia Vera | 4.2% |
| 299 | Sulfhemoglobinemia | 4.2% |
| 300 | Antiphospholipid Syndrome | 4.2% |
| 301 | Thrombophilia | 4.2% |
| 302 | Latex allergy | 4.2% |
| 303 | Erythrocytosis | 4.2% |
| 304 | Bone neoplasms | 4.1% |
| 305 | Leukoplakia | 4.1% |
| 306 | Pancreatic Cyst | 4.1% |
| 307 | Skin Neoplasms | 4.1% |
| 308 | Adrenocortical carcinoma | 4% |
| 309 | Barrett Esophagus | 4% |
| 310 | Breast Cyst | 4% |
| 311 | Actinic keratosis | 4% |
| 312 | Mediastinal Cyst | 4% |
| 313 | Neoplasm Invasiveness | 4% |
| 314 | Neoplasm Metastasis | 4% |
| 315 | Neoplasm Recurrence, Local | 4% |
| 316 | Parovarian Cyst | 4% |
| 317 | Pericardial Cyst | 4% |
| 318 | Thymic Cyst | 4% |
| 319 | Carcinogenesis | 4% |
| 320 | Myxoid cyst | 4% |
| 321 | Metastasis | 4% |
| 322 | Leydig Cell Tumor | 3.9% |
| 323 | Parathyroid Neoplasms | 3.8% |
| 324 | Peritoneal Neoplasms | 3.8% |
| 325 | Thyroid Neoplasm | 3.8% |
| 326 | Thyroid carcinoma | 3.8% |
| 327 | Thrombasthenia | 3.8% |
| 328 | Antithrombin III Deficiency | 3.8% |
| 329 | Protein C Deficiency | 3.8% |
| 330 | Liver Neoplasms, Experimental | 3.7% |
| 331 | Dupuytren Contracture | 3.7% |
| 332 | Lambert-Eaton Myasthenic Syndrome | 3.7% |
| 333 | Urticaria Pigmentosa | 3.7% |
| 334 | Nasopharyngeal carcinoma | 3.6% |
| 335 | Renal Cell Carcinoma | 3.6% |
| 336 | Papillary Renal Cell Carcinoma | 3.6% |
| 337 | Environmental Illness | 3.5% |
| 338 | Carcinoma, Endometrioid | 3.5% |
| 339 | Wiskott-Aldrich Syndrome | 3.5% |
| 340 | Pancreatic Neoplasm | 3.4% |
| 341 | Lupus Erythematosus, Systemic | 3.4% |
| 342 | Pregnancy Complications, Hematologic | 3.4% |
| 343 | Overlap syndrome | 3.4% |
| 344 | Tracheal Neoplasms | 3.3% |
| 345 | Addison Disease | 3.3% |
| 346 | Pemphigus | 3.3% |
| 347 | Autoimmune thyroiditis | 3.3% |
| 348 | Primary Adrenal Insufficiency | 3.3% |
| 349 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 3.3% |
| 350 | Autoimmune hepatitis | 3.3% |
| 351 | Corpus Luteum Cyst | 3.3% |
| 352 | Ovarian Cysts | 3.3% |
| 353 | Eosinophilic Granuloma | 3.3% |
| 354 | Leukoplakia, Oral | 3.3% |
| 355 | Retroperitoneal Neoplasms | 3.3% |
| 356 | Splenosis | 3.3% |
| 357 | Afibrinogenemia | 3.3% |
| 358 | Factor VII Deficiency | 3.3% |
| 359 | Factor X Deficiency | 3.3% |
| 360 | Factor XII Deficiency | 3.3% |
| 361 | Hemophilia A | 3.3% |
| 362 | Paraneoplastic Cerebellar Degeneration | 3.3% |
| 363 | Activated Protein C Resistance | 3.3% |
| 364 | Factor II deficiency | 3.3% |
| 365 | Factor VIII Deficiency | 3.3% |
| 366 | Factor V deficiency | 3.3% |
| 367 | Factor XI Deficiency | 3.3% |
| 368 | Hypoprothrombinemias | 3.3% |
| 369 | Vitamin K Deficiency | 3.3% |
| 370 | Thrombocytosis | 3.3% |
| 371 | Job Syndrome | 3.3% |
| 372 | Denys-Drash Syndrome | 3.3% |
| 373 | Hydrops Fetalis | 3.1% |
| 374 | Kernicterus | 3% |
| 375 | Choledochal Cyst | 2.9% |
| 376 | Esophageal Neoplasms | 2.9% |
| 377 | Limbic Encephalitis | 2.9% |
| 378 | Peutz-Jeghers Syndrome | 2.8% |
| 379 | Thyroid Nodule | 2.8% |
| 380 | Latent Autoimmune Diabetes in Adults | 2.8% |
| 381 | Dermatitis Herpetiformis | 2.8% |
| 382 | Kounis Syndrome | 2.8% |
| 383 | HIV Infections | 2.8% |
| 384 | Chronic granulomatous disease | 2.7% |
| 385 | Myelitis, Transverse | 2.7% |
| 386 | Mouth Neoplasms | 2.7% |
| 387 | Central Nervous System Neoplasms | 2.7% |
| 388 | Vascular Neoplasms | 2.7% |
| 389 | Genital Neoplasms, Female | 2.6% |
| 390 | Pancreatic Pseudocyst | 2.6% |
| 391 | Lymphatic Metastasis | 2.6% |
| 392 | Neoplasms, Unknown Primary | 2.6% |
| 393 | Leukemic Infiltration | 2.6% |
| 394 | Breast Neoplasms, Male | 2.6% |
| 395 | Neoplasm Micrometastasis | 2.6% |
| 396 | Triple Negative Breast Neoplasms | 2.6% |
| 397 | Hemoglobinuria, Paroxysmal | 2.6% |
| 398 | Leukemoid Reaction | 2.6% |
| 399 | Testicular Neoplasms | 2.6% |
| 400 | Asthma, Aspirin-Induced | 2.5% |
| 401 | anaphylaxis | 2.5% |
| 402 | Anemia, Hemolytic | 2.5% |
| 403 | Anemia, Macrocytic | 2.5% |
| 404 | Eosinophilia | 2.5% |
| 405 | Food Allergy | 2.5% |
| 406 | Hypoproteinemia | 2.5% |
| 407 | Leukopenia | 2.5% |
| 408 | Thrombocytopenia | 2.5% |
| 409 | Leukostasis | 2.5% |
| 410 | MYELODYSPLASTIC SYNDROME | 2.5% |
| 411 | Anaphylactic shock | 2.5% |
| 412 | Rheumatoid Arthritis | 2.4% |
| 413 | Juvenile arthritis | 2.4% |
| 414 | Graves Disease | 2.4% |
| 415 | Anti-Glomerular Basement Membrane Disease | 2.3% |
| 416 | Serum Sickness | 2.3% |
| 417 | Opsoclonus-Myoclonus Syndrome | 2.3% |
| 418 | Purpura, Thrombotic Thrombocytopenic | 2.3% |
| 419 | Anemia, Diamond-Blackfan | 2.3% |
| 420 | Adrenal Gland Neoplasms | 2.2% |
| 421 | Gastrointestinal Neoplasms | 2.2% |
| 422 | Genital Neoplasms, Male | 2.2% |
| 423 | Liver neoplasms | 2.2% |
| 424 | Uveal Neoplasms | 2.2% |
| 425 | Urologic Neoplasms | 2.2% |
| 426 | Sebaceous Gland Neoplasms | 2.2% |
| 427 | Spinal Neoplasms | 2.2% |
| 428 | Polycystic Ovary Syndrome | 2.2% |
| 429 | Anemia, Sickle Cell | 2.1% |
| 430 | Thalassemia | 2.1% |
| 431 | Respiratory Hypersensitivity | 2.1% |
| 432 | Nose Neoplasms | 2% |
| 433 | Anemia, Neonatal | 2% |
| 434 | Leukocytosis | 2% |
| 435 | Pelger-Huet Anomaly | 2% |
| 436 | Sick Building Syndrome | 2% |
| 437 | Pleocytosis | 2% |
| 438 | Multiple Chemical Sensitivity | 2% |
| 439 | Palatal Neoplasms | 2% |
| 440 | Urticaria | 2% |
| 441 | Vasculitis, Leukocytoclastic, Cutaneous | 2% |
| 442 | HTLV-I Infections | 2% |
| 443 | Meningeal Neoplasms | 2% |
| 444 | Pituitary Adenoma | 1.8% |
| 445 | Pituitary Neoplasms | 1.8% |
| 446 | Xeroderma Pigmentosum | 1.8% |
| 447 | Ear Neoplasms | 1.7% |
| 448 | Eyelid Neoplasms | 1.7% |
| 449 | Lung Neoplasms | 1.7% |
| 450 | Pleural Neoplasms | 1.7% |
| 451 | Ataxia Telangiectasia | 1.7% |
| 452 | Myasthenia Gravis | 1.7% |
| 453 | Uveomeningoencephalitic Syndrome | 1.7% |
| 454 | ovarian neoplasm | 1.6% |
| 455 | Drug Eruptions | 1.6% |
| 456 | Ecchymosis | 1.6% |
| 457 | Petechiae | 1.6% |
| 458 | Purpura | 1.6% |
| 459 | Cell Transformation, Viral | 1.6% |
| 460 | Brain Neoplasms | 1.6% |
| 461 | Salivary Gland Neoplasms | 1.6% |
| 462 | Spinal Cord Neoplasms | 1.6% |
| 463 | Tongue Neoplasms | 1.6% |
| 464 | Granulomatosis with polyangiitis | 1.6% |
| 465 | Dermatitis, Allergic Contact | 1.6% |
| 466 | Primary Myelofibrosis | 1.6% |
| 467 | Agranulocytosis | 1.6% |
| 468 | Anemia, Megaloblastic | 1.6% |
| 469 | HIV Seropositivity | 1.6% |
| 470 | Lymphocytosis | 1.6% |
| 471 | Myelofibrosis | 1.6% |
| 472 | Myeloid Metaplasia | 1.6% |
| 473 | Purpura, Hyperglobulinemic | 1.6% |
| 474 | Milk Allergy | 1.6% |
| 475 | Hypoalbuminemia | 1.6% |
| 476 | Wheat Hypersensitivity | 1.6% |
| 477 | Hypereosinophilic syndrome | 1.6% |
| 478 | bone marrow fibrosis | 1.6% |
| 479 | Thrombotic Microangiopathies | 1.6% |
| 480 | Uterine Neoplasms | 1.6% |
| 481 | Vaginal Neoplasms | 1.6% |
| 482 | Vulvar Neoplasms | 1.6% |
| 483 | Uterine Cancer | 1.6% |
| 484 | Meningeal Carcinomatosis | 1.6% |
| 485 | Fallopian Tube Neoplasms | 1.6% |
| 486 | Hemolytic-Uremic Syndrome | 1.6% |
| 487 | Sickle Cell Trait | 1.5% |
| 488 | Pharyngeal Neoplasms | 1.4% |
| 489 | Myasthenia Gravis, Autoimmune, Experimental | 1.4% |
| 490 | Stiff-Person Syndrome | 1.4% |
| 491 | Polyradiculoneuropathy | 1.4% |
| 492 | Polyradiculoneuritis | 1.4% |
| 493 | Central Nervous System Cysts | 1.4% |
| 494 | Acquired Immunodeficiency Syndrome | 1.4% |
| 495 | AIDS related complex | 1.4% |
| 496 | Bile Duct Neoplasms | 1.4% |
| 497 | gallbladder neoplasm | 1.4% |
| 498 | Intestinal Neoplasms | 1.4% |
| 499 | Penile Neoplasms | 1.4% |
| 500 | Prostatic Neoplasms | 1.4% |
| 501 | Stomach Neoplasms | 1.4% |
| 502 | Felty Syndrome | 1.4% |
| 503 | Fanconi Anemia | 1.4% |
| 504 | Lupus Nephritis | 1.4% |
| 505 | Bronchial Neoplasms | 1.4% |
| 506 | Multiple Pulmonary Nodules | 1.4% |
| 507 | Supratentorial Neoplasms | 1.3% |
| 508 | Waterhouse-Friderichsen Syndrome | 1.3% |
| 509 | Endometrial Neoplasms | 1.3% |
| 510 | Zollinger-Ellison syndrome | 1.3% |
| 511 | Laryngeal neoplasm | 1.3% |
| 512 | Atypical Hemolytic Uremic Syndrome | 1.3% |
| 513 | AIDS-Related Opportunistic Infections | 1.3% |
| 514 | Vasculitis, Central Nervous System | 1.2% |
| 515 | Dermatitis, Atopic | 1.2% |
| 516 | HIV Wasting Syndrome | 1.2% |
| 517 | Bladder Neoplasm | 1.2% |
| 518 | Kidney Neoplasm | 1.2% |
| 519 | Ureteral Neoplasms | 1.2% |
| 520 | Urethral Neoplasms | 1.2% |
| 521 | Rheumatoid Vasculitis | 1.2% |
| 522 | AIDS Dementia Complex | 1.2% |
| 523 | AIDS-Associated Nephropathy | 1.2% |
| 524 | Neutropenia | 1.2% |
| 525 | Brain Stem Neoplasms | 1.2% |
| 526 | Acute Chest Syndrome | 1.2% |
| 527 | Hypopharyngeal Neoplasms | 1.2% |
| 528 | Pleural Effusion, Malignant | 1.2% |
| 529 | Hypopharyngeal Cancer | 1.2% |
| 530 | Lupus Vasculitis, Central Nervous System | 1.2% |
| 531 | Parotid Neoplasms | 1.2% |
| 532 | Prostatic Neoplasms, Castration-Resistant | 1.2% |
| 533 | Nelson Syndrome | 1.2% |
| 534 | Choroid Plexus Papilloma | 1.1% |
| 535 | Eosinophilia-Myalgia Syndrome | 1.1% |
| 536 | Angioedema | 1.1% |
| 537 | Niemann-Pick Disease, Type C | 1.1% |
| 538 | Multiple Sclerosis | 1.1% |
| 539 | Shwartzman Phenomenon | 1.1% |
| 540 | Sicca Syndrome | 1.1% |
| 541 | Sjogren's Syndrome | 1.1% |
| 542 | Scurvy | 1.1% |
| 543 | Purpura Fulminans | 1.1% |
| 544 | Acute Generalized Exanthematous Pustulosis | 1.1% |
| 545 | HIV-Associated Lipodystrophy Syndrome | 1.1% |
| 546 | Tonsillar Neoplasms | 1% |
| 547 | Neuromyelitis Optica | 1% |
| 548 | Cerebellar Neoplasms | 1% |
| 549 | Leukoencephalitis, Acute Hemorrhagic | 1% |
| 550 | Cecal Neoplasms | 1% |
| 551 | Duodenal Neoplasms | 1% |
| 552 | Febrile Neutropenia | 1% |
| 553 | Pulmonary Eosinophilia | 1% |
| 554 | Eosinophilic Pneumonia | 1% |
| 555 | Anemia, Pernicious | 1% |
| 556 | Asthma | 1% |
| 557 | Encephalomyelitis, Acute Disseminated | 0.9% |
| 558 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 0.9% |
| 559 | Erythema Nodosum | 0.9% |
| 560 | Neuritis, Autoimmune, Experimental | 0.9% |
| 561 | Dermatitis, Photoallergic | 0.9% |
| 562 | Nasopharyngeal Neoplasms | 0.9% |
| 563 | Radicular Cyst | 0.9% |
| 564 | Appendiceal Neoplasms | 0.9% |
| 565 | Colonic Neoplasms | 0.9% |
| 566 | Rectal Neoplasms | 0.9% |
| 567 | Colorectal Neoplasms | 0.9% |
| 568 | Paranasal Sinus Neoplasms | 0.8% |
| 569 | Aspergillosis, Allergic Bronchopulmonary | 0.8% |
| 570 | Guillain-Barre Syndrome | 0.8% |
| 571 | Asthma, Exercise-Induced | 0.8% |
| 572 | Status Asthmaticus | 0.8% |
| 573 | Multiple Sclerosis, Chronic Progressive | 0.8% |
| 574 | Multiple Sclerosis, Relapsing-Remitting | 0.8% |
| 575 | Anus Neoplasms | 0.8% |
| 576 | Sigmoid Neoplasms | 0.8% |
| 577 | Maxillary Sinus Neoplasms | 0.7% |
| 578 | Asthma, Occupational | 0.7% |
| 579 | Toxic Epidermal Necrolysis | 0.7% |
| 580 | Stevens-Johnson Syndrome | 0.7% |
| 581 | Farmer's Lung | 0.7% |
| 582 | Angioedemas, Hereditary | 0.7% |
| 583 | Hay fever | 0.7% |
| 584 | Rhinitis, Allergic, Perennial | 0.7% |
| 585 | Hereditary Angioedema Type III | 0.7% |
| 586 | Hereditary Angioedema Types I and II | 0.7% |
| 587 | Pseudoxanthoma Elasticum | 0.7% |
| 588 | Giant Cell Arteritis | 0.7% |
| 589 | Temporal Arteritis | 0.7% |
| 590 | Miller Fisher Syndrome | 0.4% |